Beasley TM - Search Results

1

Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.

Liu N, Irvin MR, Zhi D, Patki A, Beasley TM, Nickerson DA, Hill CE, Chen J, Kimmel SE, Limdi NA. Liu N, et al. Among authors: beasley tm. Pharmacogenomics. 2017 Jul;18(11):1059-1073. doi: 10.2217/pgs-2017-0046. Epub 2017 Jul 7. Pharmacogenomics. 2017. PMID: 28686080 Free PMC article.

2

Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.

Limdi NA, Brown TM, Shendre A, Liu N, Hill CE, Beasley TM. Limdi NA, et al. Among authors: beasley tm. Pharmacogenet Genomics. 2017 Oct;27(10):347-355. doi: 10.1097/FPC.0000000000000298. Pharmacogenet Genomics. 2017. PMID: 28806200 Free PMC article.

3

Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Shendre A, Parmar GM, Dillon C, Beasley TM, Limdi NA. Shendre A, et al. Among authors: beasley tm. Pharmacotherapy. 2018 Jun;38(6):588-596. doi: 10.1002/phar.2089. Epub 2018 Feb 27. Pharmacotherapy. 2018. PMID: 29393514 Free PMC article.

4

Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.

Shendre A, Brown TM, Liu N, Hill CE, Beasley TM, Nickerson DA, Limdi NA. Shendre A, et al. Among authors: beasley tm. Pharmacotherapy. 2016 Mar;36(3):263-72. doi: 10.1002/phar.1717. Epub 2016 Mar 14. Pharmacotherapy. 2016. PMID: 26877068 Free PMC article.

5

Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Yanik MV, Irvin MR, Beasley TM, Jacobson PA, Julian BA, Limdi NA. Yanik MV, et al. Among authors: beasley tm. Pharmacotherapy. 2017 Nov;37(11):1366-1373. doi: 10.1002/phar.2032. Epub 2017 Nov 2. Pharmacotherapy. 2017. PMID: 28949423 Free PMC article.

6

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.

Limdi NA, Arnett DK, Goldstein JA, Beasley TM, McGwin G, Adler BK, Acton RT. Limdi NA, et al. Among authors: beasley tm. Pharmacogenomics. 2008 May;9(5):511-26. doi: 10.2217/14622416.9.5.511. Pharmacogenomics. 2008. PMID: 18466099 Free PMC article.

7

VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.

Limdi NA, Beasley TM, Crowley MR, Goldstein JA, Rieder MJ, Flockhart DA, Arnett DK, Acton RT, Liu N. Limdi NA, et al. Among authors: beasley tm. Pharmacogenomics. 2008 Oct;9(10):1445-58. doi: 10.2217/14622416.9.10.1445. Pharmacogenomics. 2008. PMID: 18855533 Free PMC article.

8

Race influences warfarin dose changes associated with genetic factors.

Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, Hill CE, Arnett DK, Beasley TM. Limdi NA, et al. Among authors: beasley tm. Blood. 2015 Jul 23;126(4):539-45. doi: 10.1182/blood-2015-02-627042. Epub 2015 May 29. Blood. 2015. PMID: 26024874 Free PMC article.

9

Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.

Ather S, Shendre A, Beasley TM, Brown T, Hill CE, Prabhu SD, Limdi NA. Ather S, et al. Among authors: beasley tm. Am J Cardiol. 2016 Jul 15;118(2):232-6. doi: 10.1016/j.amjcard.2016.04.047. Epub 2016 May 5. Am J Cardiol. 2016. PMID: 27241839 Free PMC article.

10

Warfarin dosing in patients with impaired kidney function.

Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon M, Beasley TM. Limdi NA, et al. Among authors: beasley tm. Am J Kidney Dis. 2010 Nov;56(5):823-31. doi: 10.1053/j.ajkd.2010.05.023. Epub 2010 Aug 14. Am J Kidney Dis. 2010. PMID: 20709439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page